In the evolving landscape of HIV care, treatment success depends not only on antiviral efficacy, but also on long-term tolerability, convenience, and patient adherence. Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide tablets) is a well-established, single-tablet regimen designed to support durable viral suppression while simplifying daily treatment for people living with HIV-1....
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
